U.S. pharma huge copyright scrapped two experimental weight loss drugs past 12 months—a at the time-everyday capsule, lotiglipron, due to elevated liver enzymes and also a twice-daily pill, danuglipron, resulting from robust side effects—but CEO Albert Bourla has mentioned the company is set to “Enjoy and gain” during the obesity Place and